pA2 online
© Copyright 2004 The British Pharmacological Society

023P University of Bath
Summer Meeting July 2004

I2 binding in MAO-A knockout mouse kidneys


Anderson NJ, Seif I*, Nutt DJ, Hudson AL & Robinson ESJ. Psychopharmacology Unit, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY *Sérotonine et Neuropharmacologie, EA 3544, Tour D1 - 2ème étage, University de Paris-Sud, 92296 Chatenay-Malabry, France

Print abstract

Search PubMed for:


Anderson NJ
Seif I
Nutt DJ
Hudson AL
Hudson ESJ

The imidazoline2 binding sites (I2BS) have been described in a number of species. I2BS selective compounds are known to inhibit the monoamine oxidase A and B (MAO) isozymes at micromolar concentrations. A previous study looking at [3H]idazoxan labelling of I2BS in whole brain homogenates of MAO-A and MAO-B knockout mice concluded that I2BS are located exclusively on the B isoform (Remaury et al., 2000). However, studies in our laboratory suggest that the population of I2BS and autoradiographical distribution do not exclusively correlate with MAO-A or B. The aim of this study was to use the highly selective I2BS ligand [3H]2BFI to investigate I2BS in mouse kidneys devoid of functional MAO-A. The results have been compared with data from wildtype animals in order to profile the extent of I2BS associated with MAO-A.

Kidneys from C3H/He mice of both sexes (8 MAO-A knockout (KO) and 8 wildtype (WT); Cases et al., 1995) were obtained, and 20 µm sections cut. Sequential sections were incubated with the radioligands at room temperature as follows, specific binding and wash protocols were as published (Lione et al., 1998; Saura et al., 1994): 3 nM [3H]Ro41-1049 (60 min), 5 nM [ 3H]idazoxan + 5 µM rauwolscine (40 min) and 1.5 nM [ 3H]2BFI (40 min). The labelled sections were apposed to Kodak Biomax film with tritium standards. The regional binding (cortex, inner and outer medulla) was quantified by computer aided densitometry (MCID 5, Imaging Associates, UK).

The regional labelling of MAO-A ([3H]Ro41-1049) in the wild-type kidneys concurred with previously published data (Saura et al., 1994). In the knockout kidneys, MAO-A binding was reduced to background levels (two way ANOVA, P<0.0001). I2 binding as shown by [ 3H]idazoxan (+ rauwolscine) was also significantly lower (P<0.0001) in the knockouts, and this finding was replicated using the selective I2 radioligand [3H]2BFI (Table 1). In conclusion, these data indicate that in kidney at least, I2 binding is in part associated with MAO-A.

[3H]Ro41-1049

[3H]idazoxan

[3H]2BFI

WT

KO

WT

KO

WT

KO

Cortex

142.4 ± 20.8

5.7 ± 7.2

14.5 ± 3.9

7.9 ± 1.2

10.4 ± 3.2

4.7 ± 0.8

Medulla
inner

56.4 ± 18.4

3.2 ± 3.4

7.6 ± 2.9

4.7 ± 2.1

5.6 ±1.5

3.4 ± 1.1

outer

222.4 ± 25.2

4.7 ± 4.3

5.9 ± 2.9

2.6 ± 1.2

4.2 ± 1.2

0.7 ± 0.6

Table 1 – MAO-A ([3H]Ro41-1049) and I2 ([3H]idazoxan and [3H]2BFI) binding to the mouse kidney sections. Data are expressed in fmol.mg -1 wet tissue ± the standard deviation.

Cases, O, et al. (1995) Science, 268, 1763-6
Lione, LA, et al. (1998) Eur. J. Pharmacol., 353, 123-35
Remaury, A, et al. (2000) Mol. Pharmacol., 58, 1085-90
Saura, J, et al. (1994) Neurobiol. Aging, 15, 399-408

[3H]Ro41-1049 was kindly donated by Dr. Borroni at Hoffmann La Roche